April 3 Versartis Inc:
* Three-year Vertical/Vista study results support selection of 3.5 mg/kg twice-monthly dose regimen for phase 3 Velocity trial underway Source text for Eikon: Further company coverage:
Itaú's Setubal sees high growth at Brazil's XP
SAO PAULO, June 24 The price that Itaú Unibanco Holding SA paid for a minority stake in Brazilian independent securities firm XP Investimentos SA embeds "very high growth rates" ahead, co-Chairman Roberto Setubal said on Saturday.
UPDATE 1-Arconic knowingly supplied flammable panels for use in tower -emails
LONDON, June 24 Six emails sent by and to an Arconic Inc sales manager raise questions about why the company supplied combustible cladding to a distributor for use at Grenfell Tower, despite publicly warning such panels were a fire risk for tall buildings.